Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Division
DTMC
HEAL Study
No
Investigator(s)
Thomas F. Newton, M.D.
Title
Assessment of Interactions Between Methamphetamine and Aripiprazole
Short Description
The purpose of this study is to assess the interactions between intravenous methamphetamine and aripiprazole.
Release Date
May 07, 2018
Description

This is a double-blind, placebo-controlled human laboratory clinical pharmacology study to assess potential interactions between intravenous d-methamphetamine infusion and treatment with oral aripiprazole.

Keywords
Aripiprazole
interaction
methamphetamine
phase 1b
stimulant
Assessments
Addiction Research Center Inventory
Beck Depression Inventory
Blood Methamphetamine Level
Brief Substance Craving Scale
Brief Symptom Inventory
ECG Monitoring
Profile of Mood States
Urine Methamphetamine Level
Visual Analog Scales
Vital Signs Monitoring
Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Data
MDS-0002 Data
Study Links
Primary Manuscript
https://www.ncbi.nlm.nih.gov/pubmed/18664303
ClinicalTrials.gov Link
https://clinicaltrials.gov/ct2/show/NCT00089440
Study Documents
Protocol
MDS0002-Protocol.pdf
Dictionary
MDS0002_DD.xlsx
Case Report Form(s)
MDS0002-CRF.pdf
Deidentification Notes
MDS0002-DeidentificationNotes.pdf
Nulled Values
MDS0002-nulled-values.csv
All Documents
MDS0002 - AllDocuments.zip
Division
DTMC
HEAL Study
No
Investigator(s)
Thomas F. Newton, M.D.
Title
Assessment of Potential Interactions Between Methamphetamine and Bupropion
Short Description
The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.
Release Date
May 07, 2018
Description

This is a human laboratory clinical pharmacology study to assess potential interactions between IV methamphetamine challenge and treatment with oral sustained-release bupropion.

Keywords
bupropion
interaction
methamphetamine
phase 1b
stimulant
Assessments
Addiction Research Center Inventory
Beck Depression Inventory
Blood Methamphetamine Level
Blood Study Agent Level
Brief Symptom Inventory
ECG Monitoring
Profile of Mood States
Urine Methamphetamine Level
Visual Analog Scales
Vital Signs Monitoring
Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Data
CTO-0010 Data
Study Links
Primary Manuscript
https://www.nature.com/articles/1300979
ClinicalTrials.gov Link
https://clinicaltrials.gov/ct2/show/NCT00040040
Study Documents
Protocol
CTO0010-Protocol.pdf
Dictionary
CTO0010_DD.xlsx
Case Report Form(s)
CTO0010-CRF.pdf
Deidentification Notes
CTO0010-DeidentificationNotes.pdf
Nulled Values
CTO0010-nulled-values.csv
All Documents
CTO0010 - AllDocuments.zip

Wechsler Adult Intelligence Scale Digit Symbol subtest

Submitted by administrator -
Abbreviation
WAIS-Digit
Description

The WAIS-R consists of six verbal subtests and five performance subtests. The verbal tests are: Information, Comprehension, Arithmetic, Digit Span, Similarities, and Vocabulary. The Performance subtests are: Picture Arrangement, Picture Completion, Block Design, Object Assembly, and Digit Symbol.

Category
Impulsivity and General Trait & Behavior Scales
Subscribe to